Preferred Label : AAVD Regimen;
NCIt synonyms : AAVD; Brentuximab Vedotin/Dacarbazine/Doxorubicin/Vinblastine; Brentuximab Vedotin/Dacarbazine/Doxorubicin/Vinblastine Regimen; Adcetris/Adriamycin/Vinblastine/Dacarbazine; Adcetris/Adriamycin/Vinblastine/Dacarbazine Regimen; AVD-A; B-AVD; A AVD; A AVD; A-AVD; Doxorubicin/Vinblastine/Dacarbazine Plus Brentuximab Vedotin; AVD Plus Brentuximab Vedotin; Brentuximab Vedotin-Dacarbazine-Doxorubicin-Vinblastine; Brentuximab Vedotin Followed by AVD; Brentuximab Vedotin/AVD Regimen; A AVD Regimen; Brentuximab Vedotin Plus AVD Regimen; Brentuximab Vedotin/Doxorubicin/Vinblastine/Dacarbazine; BV-AVD Regimen; AVD/Brentuximab Vedotin Regimen; Brentuximab Vedotin Plus Dacarbazine-Doxorubicin-Vinblastine;
NCIt related terms : A-AVD;
NCIt definition : A regimen consisting of brentuximab vedotin, doxorubicin, vinblastine and dacarbazine
that can be used in the treatment of Hodgkin lymphoma (HL).;
NCI Metathesaurus CUI : CL969503;
Codes from synonyms : 22609;
Origin ID : C160563;
UMLS CUI : C5205359;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
